Matrix Assisted Laser Desorption Ionisation/Time Of Flight (MALDI/TOF) mass spectrometry is not done revolutionizing clinical microbiology diagnostic

Affiliations

¹ Hospices Civils de Lyon, 24/7 Microbiology Platform, Institut des Agents Infectieux, Centre de Biologie et Pathologie Nord, Lyon, France; Centre International de Recherche en Infectiologie, Inserm U1111, Université Claude Bernard Lyon 1, Lyon, France. Electronic address: olivier.dauwalder@chu-lyon.fr.
² Hospices Civils de Lyon, 24/7 Microbiology Platform, Institut des Agents Infectieux, Centre de Biologie et Pathologie Nord, Lyon, France.
³ Hospices Civils de Lyon, 24/7 Microbiology Platform, Institut des Agents Infectieux, Centre de Biologie et Pathologie Nord, Lyon, France; Centre International de Recherche en Infectiologie, Inserm U1111, Université Claude Bernard Lyon 1, Lyon, France.

Free article

Comment

Olivier Dauwalder et al. Clin Microbiol Infect. 2023 Feb.

Free article

. 2023 Feb;29(2):127-129.

doi: 10.1016/j.cmi.2022.10.005. Epub 2022 Oct 8.

¹ Hospices Civils de Lyon, 24/7 Microbiology Platform, Institut des Agents Infectieux, Centre de Biologie et Pathologie Nord, Lyon, France; Centre International de Recherche en Infectiologie, Inserm U1111, Université Claude Bernard Lyon 1, Lyon, France. Electronic address: olivier.dauwalder@chu-lyon.fr.
² Hospices Civils de Lyon, 24/7 Microbiology Platform, Institut des Agents Infectieux, Centre de Biologie et Pathologie Nord, Lyon, France.
³ Hospices Civils de Lyon, 24/7 Microbiology Platform, Institut des Agents Infectieux, Centre de Biologie et Pathologie Nord, Lyon, France; Centre International de Recherche en Infectiologie, Inserm U1111, Université Claude Bernard Lyon 1, Lyon, France.

No abstract available

Keywords: External quality controls; MALDI TOF mass spectrometry; Mass spectra quality; Reproducibility; Resistance prediction; Typing.

Comment on

Quality of MALDI-TOF mass spectra in routine diagnostics: results from an international external quality assessment including 36 laboratories from 12 countries using 47 challenging bacterial strains.
Cuénod A, Aerni M, Bagutti C, Bayraktar B, Boz ES, Carneiro CB, Casanova C, Coste AT, Damborg P, van Dam DW, Demirci M, Drevinek P, Dubuis O, Fernandez J, Greub G, Hrabak J, Hürkal Yiğitler G, Hurych J, Jensen TG, Jost G, Kampinga GA, Kittl S, Lammens C, Lang C, Lienhard R, Logan J, Maffioli C, Mareković I, Marschal M, Moran-Gilad J, Nolte O, Oberle M, Pedersen M, Pflüger V, Pranghofer S, Reichl J, Rentenaar RJ, Riat A, Rodríguez-Sánchez B, Schilt C, Schlotterbeck AK, Schrenzel J, Troib S, Willems E, Wootton M, Ziegler D, Egli A; ESGMD study group. Cuénod A, et al. Clin Microbiol Infect. 2023 Feb;29(2):190-199. doi: 10.1016/j.cmi.2022.05.017. Epub 2022 May 25. Clin Microbiol Infect. 2023. PMID: 35623578